FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080352912> ?p ?o ?g. }

• W2080352912 endingPage "26483" @default.
• W2080352912 startingPage "26477" @default.
• W2080352912 abstract "Extracellular heat shock proteins (HSPs) can stimulate antigen-specific immune responses. Using recombinant human (rhu)Hsp70, we previously demonstrated that through complex formation with exogenous antigenic peptides, rhuHsp70 can enhance cross-presentation by antigen-presenting cells (APCs) resulting in stronger T cell stimulation. T cell stimulatory activity has also been described for mycobacterial (myc)Hsp70. MycHsp70-assisted T cell activation has been reported to act through the binding of mycHsp70 to chemokine receptor 5 (CCR5), calcium signaling, phenotypic maturation, and cytokine secretion by dendritic cells (DCs). We report that highly purified rhuHsp70 and mycHsp70 proteins both strongly enhance cross-presentation of exogenous antigens. Augmentation of cross-presentation was seen for different APCs, irrespective of CCR5 expression. Moreover, neither of the purified Hsp70 proteins induced calcium signals in APCs. Instead, calcium signaling activity was found to be caused by contaminating nucleotides present in Hsp70 protein preparations. These results refute the hypothesis that mycHsp70 proteins require CCR5 expression and calcium signaling by APCs for enhanced antigen cross-presentation for T cell stimulation. Extracellular heat shock proteins (HSPs) can stimulate antigen-specific immune responses. Using recombinant human (rhu)Hsp70, we previously demonstrated that through complex formation with exogenous antigenic peptides, rhuHsp70 can enhance cross-presentation by antigen-presenting cells (APCs) resulting in stronger T cell stimulation. T cell stimulatory activity has also been described for mycobacterial (myc)Hsp70. MycHsp70-assisted T cell activation has been reported to act through the binding of mycHsp70 to chemokine receptor 5 (CCR5), calcium signaling, phenotypic maturation, and cytokine secretion by dendritic cells (DCs). We report that highly purified rhuHsp70 and mycHsp70 proteins both strongly enhance cross-presentation of exogenous antigens. Augmentation of cross-presentation was seen for different APCs, irrespective of CCR5 expression. Moreover, neither of the purified Hsp70 proteins induced calcium signals in APCs. Instead, calcium signaling activity was found to be caused by contaminating nucleotides present in Hsp70 protein preparations. These results refute the hypothesis that mycHsp70 proteins require CCR5 expression and calcium signaling by APCs for enhanced antigen cross-presentation for T cell stimulation. Recent evidence has demonstrated that heat shock proteins (HSPs), 2The abbreviations used are: HSPheat shock protein familyAPCantigen-presenting cellCCRchemokine receptorCTLcytotoxic T lymphocyteDCdendritic cellHLAhuman leukocyte antigenHsp70stress-inducible member of the 70-kD familyLCLlymphoblastoid cell linemycmycobacterialrhurecombinant humanMART-1melanoma antigen recognized by T cells-1ncnucleotidepep70peptide sequence binding to Hsp70IFNinterferonLPSlipopolysaccharide. in addition to their roles as chaperones, can stimulate antigen-specific immune responses (1Calderwood S.K. Theriault J.R. Gong J. Eur. J. Immunol. 2005; 35: 2518-2527Crossref PubMed Scopus (130) Google Scholar). This immune stimulatory activity is thought to be activated after HSPs are released from cells either through necrosis or induced secretion (2Basu S. Binder R.J. Suto R. Anderson K.M. Srivastava P.K. Int. Immunol. 2000; 12: 1539-1546Crossref PubMed Scopus (1086) Google Scholar, 3Lancaster G.I. Febbraio M.A. J. Biol. Chem. 2005; 280: 23349-23355Abstract Full Text Full Text PDF PubMed Scopus (448) Google Scholar, 4Lang A. Benke D. Eitner F. Engel D. Ehrlich S. Breloer M. Hamilton-Williams E. Specht S. Hoerauf A. Floege J. von Bonin A. Kurts C. J. Am. Soc. Nephrol. 2005; 16: 383-391Crossref PubMed Scopus (47) Google Scholar, 5Asea A. J. Biosci. 2007; 32: 579-584Crossref PubMed Scopus (77) Google Scholar). In their role as molecular chaperones, most HSPs exist in complexes with hydrophobic polypeptides. The contact of extracellular HSP:peptide complexes with dendritic cells (DCs) is thought to result in the efficient transfer of the chaperoned peptides into the antigen-presentation pathway of DCs allowing antigen-specific T cell activation. heat shock protein family antigen-presenting cell chemokine receptor cytotoxic T lymphocyte dendritic cell human leukocyte antigen stress-inducible member of the 70-kD family lymphoblastoid cell line mycobacterial recombinant human melanoma antigen recognized by T cells-1 nucleotide peptide sequence binding to Hsp70 interferon lipopolysaccharide. Mechanistically, HSP binding to surface receptors and HSP-induced signaling events are thought to be involved in antigen transfer to DCs and subsequent T cell stimulation. In this regard, a number of potential HSP receptors have been reported (6Becker T. Hartl F.U. Wieland F. J. Cell Biol. 2002; 158: 1277-1285Crossref PubMed Scopus (305) Google Scholar, 7Binder R.J. Vatner R. Srivastava P. Tissue Antigens. 2004; 64: 442-451Crossref PubMed Scopus (212) Google Scholar, 8Basu S. Binder R.J. Ramalingam T. Srivastava P.K. Immunity. 2001; 14: 303-313Abstract Full Text Full Text PDF PubMed Scopus (938) Google Scholar, 9Calderwood S.K. Mambula S.S. Gray Jr., P.J. Theriault J.R. FEBS Lett. 2007; 581: 3689-3694Crossref PubMed Scopus (274) Google Scholar). Among these, CD40 and chemokine receptor 5 (CCR5) represent two interesting possibilities as these molecules are intricately linked to T cell and DC biology (10Kim C.H. Nagata K. Butcher E.C. J. Immunol. 2003; 171: 152-158Crossref PubMed Scopus (69) Google Scholar, 11Castellino F. Huang A.Y. Altan-Bonnet G. Stoll S. Scheinecker C. Germain R.N. Nature. 2006; 440: 890-895Crossref PubMed Scopus (610) Google Scholar). In this regard, CCR5 has been reported to act as a pattern recognition receptor for mycobacterial (myc)Hsp70 thus facilitating mycobacterial defense through mycHsp70-induced DC activation and subsequent T cell stimulation. The binding of mycHsp70 to CCR5, calcium signaling in myeloid DCs, phenotypic maturation, and cytokine secretion of DCs have been reported to underlie mycHsp70-assisted T cell activation (12Floto R.A. MacAry P.A. Boname J.M. Mien T.S. Kampmann B. Hair J.R. Huey O.S. Houben E.N. Pieters J. Day C. Oehlmann W. Singh M. Smith K.G. Lehner P.J. Science. 2006; 314: 454-458Crossref PubMed Scopus (130) Google Scholar, 13Whittall T. Wang Y. Younson J. Kelly C. Bergmeier L. Peters B. Singh M. Lehner T. Eur. J. Immunol. 2006; 36: 2304-2314Crossref PubMed Scopus (54) Google Scholar). We have previously demonstrated that CCR5 can mediate unique signaling events (14Mack M. Kleinschmidt A. Bruhl H. Klier C. Nelson P.J. Cihak J. Plachy J. Stangassinger M. Erfle V. Schlondorff D. Nat. Med. 2000; 6: 769-775Crossref PubMed Scopus (466) Google Scholar, 15Weber C. Weber K.S. Klier C. Gu S. Wank R. Horuk R. Nelson P.J. Blood. 2001; 97: 1144-1146Crossref PubMed Scopus (210) Google Scholar). In addition, we have shown that human Hsp70 from melanoma cells can chaperone tumor-associated peptides (tyrosinase) and deliver them to DCs allowing cross-presentation and T cell stimulation (16Noessner E. Gastpar R. Milani V. Brandl A. Hutzler P.J. Kuppner M.C. Roos M. Kremmer E. Asea A. Calderwood S.K. Issels R.D. J. Immunol. 2002; 169: 5424-5432Crossref PubMed Scopus (220) Google Scholar). Recently, we used recombinant human (rhu)Hsp70 to define in more detail the critical parameters for the induction of immune effector responses (17Bendz H. Ruhland S.C. Pandya M.J. Hainzl O. Riegelsberger S. Brauchle C. Mayer M.P. Buchner J. Issels R.D. Noessner E. J. Biol. Chem. 2007; 282: 31688-31702Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). Highly purified and endotoxin-depleted rhuHsp70 was found to efficiently deliver exogenous peptides to DCs resulting in T cell activation, provided that peptide and Hsp70 had formed stable complexes before exposure to DCs. Phenotypic maturation or cytokine secretion of DCs was not observed and not required for the rhuHsp70-mediated enhancement of cross-presentation and T cell stimulation. Here we used highly purified rhuHsp70 and mycHsp70 proteins and examined whether mycHsp70 also enhances cross-presentation of exogenous antigenic protein sequences and tested whether calcium signaling or CCR5 were required for Hsp70-assisted antigen presentation and T cell stimulation. Reagents and Peptides—ADP, ionomycin, suramin, Escherichia coli-derived LPS (strain 0111:B4), and reagents for calcium signaling (Indo-I AM, Pluronic F-127, DMSO) were purchased from Sigma. All buffers and solutions were prepared using aqua ad injectabilia (Braun Melsungen, Germany). Peptides were purchased from Biosyntan GmbH (Berlin, Germany). The peptides were synthesized as hybrids of the nonameric HLA-A2 binding motif with the N-terminal octameric sequence HWDFAWPW (here named pep70) (pep70-MART-1: GSGHWDFAWPWGSGLAGIGILTV). Recombinant Hsp70 Proteins—Recombinant human (rhu)-Hsp70 protein was either purchased from Stressgen, Victoria, BC, Canada (ESP-555) or was prepared in our own laboratory as described (17Bendz H. Ruhland S.C. Pandya M.J. Hainzl O. Riegelsberger S. Brauchle C. Mayer M.P. Buchner J. Issels R.D. Noessner E. J. Biol. Chem. 2007; 282: 31688-31702Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). After ADP affinity chromatography, buffer was exchanged using PD10 columns followed by extensive dialysis (48 h, 5000× buffer volume) and diafiltration (Vivaspin 20, 30,000 MWCO PES, Sartorius Stedim Biotech). To assess the influence of nucleotide carryover, rhuHsp70 preparations were used after PD10 column and diafiltration with a less intensive dialysis step (Hsp70/nc+). Endotoxin was depleted, as described (17Bendz H. Ruhland S.C. Pandya M.J. Hainzl O. Riegelsberger S. Brauchle C. Mayer M.P. Buchner J. Issels R.D. Noessner E. J. Biol. Chem. 2007; 282: 31688-31702Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). Only proteins with endotoxin below 0.5 EU/mg rhuHsp70 were used. Full-length mycHsp70 was obtained from Lionex Diagnostics & Therapeutics GmbH, Braunschweig, Germany (Product: M. tuberculosis Hsp70, LRP 0003.3; batch: 07-1 lot2). The cDNA coding for the C-terminal substrate binding domain of mycHsp70, mycHsp70-(359–625), kindly provided by P. J. Lehner, Cambridge (UK), was subcloned into the vector pET21d (Novagen/EMD Chemicals, Gibbstown, NJ). C-terminally His6-tagged recombinant protein was produced in E. coli strain Rosetta2(DE3) (Invitrogen, Karlsruhe, Germany) and purified using Ni-nitrilotriacetic acid-agarose (Qiagen, Hilden, Germany) as described (18Udono H. Saito T. Ogawa M. Yui Y. Methods. 2004; 32: 21-24Crossref PubMed Scopus (14) Google Scholar). Endotoxin depletion was performed as described (17Bendz H. Ruhland S.C. Pandya M.J. Hainzl O. Riegelsberger S. Brauchle C. Mayer M.P. Buchner J. Issels R.D. Noessner E. J. Biol. Chem. 2007; 282: 31688-31702Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). APCs and Cell Cultures—DCs were differentiated from monocytes of PBMC of healthy donors (CD14+ magnetic bead selection, Miltenyi) using IL4/GM-CSF exactly as described (17Bendz H. Ruhland S.C. Pandya M.J. Hainzl O. Riegelsberger S. Brauchle C. Mayer M.P. Buchner J. Issels R.D. Noessner E. J. Biol. Chem. 2007; 282: 31688-31702Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). Cells were used without further maturation (i.e. non-matured IL4/GM-CSF-differentiated myeloid DCs). The local ethics commission approved these studies, and donors gave informed consent. Human B-lymphoblastoid B cell line (B-LCL L721.45) and CTL A42-MART (HLA-A2-restricted Melan-A/MART-1-peptide (LAGIGILTV)-specific) were cultured as described (17Bendz H. Ruhland S.C. Pandya M.J. Hainzl O. Riegelsberger S. Brauchle C. Mayer M.P. Buchner J. Issels R.D. Noessner E. J. Biol. Chem. 2007; 282: 31688-31702Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). Cross-presentation—Cross-presentation was performed exactly as described (17Bendz H. Ruhland S.C. Pandya M.J. Hainzl O. Riegelsberger S. Brauchle C. Mayer M.P. Buchner J. Issels R.D. Noessner E. J. Biol. Chem. 2007; 282: 31688-31702Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). Briefly, in parallel wells of a 96-well cell culture plate identical amounts of pep70-MART-peptide (70 nm) alone or together with rhuHsp70 (1 μm) or mycHsp70-(359–625) (1 μm) were incubated in HKM buffer (total volume of 30 μl) for 4 h at room temperature for complex formation. B-LCL 721.45 and CTL A42-MART were added resulting in a 1:7 dilution of rhuHsp70 and peptide. The concentrations declared in text/figure correspond to the final concentrations in the APC/T cell mixture. After 24 h at 37 °C, supernatants were harvested, and IFN-γ was measured by ELISA (BD OptEIA™, BD Biosciences Pharmingen). Control samples, containing all components except the peptide, were used to determine IFN-γ background, which was subtracted from the experimental samples. Flow Cytometry—Surface expression of molecules was determined by flow cytometry. 0.1 × 106 cells (DCs or B-LCL) after a 48-h incubation with 300 nm rhuHsp70, LPS (1 μg/ml) or without stimulus, were stained with specific antibodies (anti-human CD80, CD86, CD83, CD40 (all BD Biosciences Pharmingen, Heidelberg, Germany), anti-CCR5 antibody (R&D systems), anti-human CD38 (Immunotech, Hamburg, Germany), or IgG control antibodies (BD Biosciences) diluted in phosphate-buffered saline containing 2% fetal calf serum. After 30 min of incubation on ice, cells were washed and fixed with 1% PFA. Immunofluorescence analyses employed the FACSCalibur and Cell Quest software (Becton Dickinson). Cytokine Quantitation—Non-matured IL-4/GM-CSF-differentiated myeloid DCs were incubated with 300 nm rhuHsp70, LPS (1 μg/ml), or without stimuli for 48 h at 37 °C. Cytokines in the supernatants were measured using the Bio-Plex Cytokine 12-Plex Assay (Bio-Rad), and concentrations were calculated using the Bio-Plex Manager™ software program. Intracellular Calcium Analysis—Calcium analysis was performed as described, and changes in intracellular calcium were measured with MoFlo using Summit software (Dako-Cytomation) (17Bendz H. Ruhland S.C. Pandya M.J. Hainzl O. Riegelsberger S. Brauchle C. Mayer M.P. Buchner J. Issels R.D. Noessner E. J. Biol. Chem. 2007; 282: 31688-31702Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). Ionomycin (250 ng/ml), ADP solutions, mycHsp70-(359–625) (1 μm), rhuHsp70 (300 nm), mycHsp70 Lionex (1 μm), or the corresponding protein-depleted solutions (volumes corresponding to the 300 nm rhuHsp70 or 1 μm mycHsp70 protein solutions, respectively) were added 1 min after the cells were measured without stimulation for background establishment. The protein-depleted solutions were obtained by removing protein through filtration of the stock preparation through a PES membrane with 30-kDa molecular weight cutoff (Vivaspin 20, 30.000 MWCO PES). For inhibition, DCs were preincubated with 250 μm suramin for 5 min. As control, the buffers without stimulating agents were measured and did not result in a calcium signal. Calcium Signals in Myeloid DCs Are Induced by Contamination of rhuHsp70 and mycHsp70 Preparations—Published studies (12Floto R.A. MacAry P.A. Boname J.M. Mien T.S. Kampmann B. Hair J.R. Huey O.S. Houben E.N. Pieters J. Day C. Oehlmann W. Singh M. Smith K.G. Lehner P.J. Science. 2006; 314: 454-458Crossref PubMed Scopus (130) Google Scholar, 13Whittall T. Wang Y. Younson J. Kelly C. Bergmeier L. Peters B. Singh M. Lehner T. Eur. J. Immunol. 2006; 36: 2304-2314Crossref PubMed Scopus (54) Google Scholar, 19MacAry P.A. Javid B. Floto R.A. Smith K.G. Oehlmann W. Singh M. Lehner P.J. Immunity. 2004; 20: 95-106Abstract Full Text Full Text PDF PubMed Scopus (94) Google Scholar) have suggested that mycHsp70 induces a calcium signal in DCs resulting in DC maturation and antigen-specific T cell activation. Our previous results using highly purified rhuHsp70 had shown that rhuHsp70 enhances cross-presentation and T cell stimulation without changing the DC phenotype (17Bendz H. Ruhland S.C. Pandya M.J. Hainzl O. Riegelsberger S. Brauchle C. Mayer M.P. Buchner J. Issels R.D. Noessner E. J. Biol. Chem. 2007; 282: 31688-31702Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). We therefore compared and contrasted our rhuHsp70 to the same mycHsp70 preparation used in the published studies (12Floto R.A. MacAry P.A. Boname J.M. Mien T.S. Kampmann B. Hair J.R. Huey O.S. Houben E.N. Pieters J. Day C. Oehlmann W. Singh M. Smith K.G. Lehner P.J. Science. 2006; 314: 454-458Crossref PubMed Scopus (130) Google Scholar, 13Whittall T. Wang Y. Younson J. Kelly C. Bergmeier L. Peters B. Singh M. Lehner T. Eur. J. Immunol. 2006; 36: 2304-2314Crossref PubMed Scopus (54) Google Scholar, 19MacAry P.A. Javid B. Floto R.A. Smith K.G. Oehlmann W. Singh M. Lehner P.J. Immunity. 2004; 20: 95-106Abstract Full Text Full Text PDF PubMed Scopus (94) Google Scholar) for its ability to induce calcium signals in DCs. Hsp70 proteins, mycobacterial, and human, recombinantly expressed in E. coli, are generally purified using ATP affinity chromatography, ATP elution, and buffer exchange (20Buchberger A. Schroder H. Buttner M. Valencia A. Bukau B. Nat. Struct. Biol. 1994; 1: 95-101Crossref PubMed Scopus (113) Google Scholar). Nucleotides are documented inducers of calcium signals in immune cells (21la Sala A. Ferrari D. Corinti S. Cavani A. Di Virgilio F. Girolomoni G. J. Immunol. 2001; 166: 1611-1617Crossref PubMed Scopus (188) Google Scholar, 22Marteau F. Communi D. Boeynaems J.M. Suarez Gonzalez N. J. Leukoc Biol. 2004; 76: 796-803Crossref PubMed Scopus (70) Google Scholar, 23Schnurr M. Toy T. Shin A. Wagner M. Cebon J. Maraskovsky E. Blood. 2005; 105: 1582-1589Crossref PubMed Scopus (182) Google Scholar). Therefore, we suspected that residual ATP or ADP could have caused the reported calcium effect. To control for possible artifacts evoked by contaminants in the protein solution, we prepared a protein-depleted solution by separating the mycHsp70 protein from the protein solution by centrifugation through a membrane with a 30-kDa cutoff. SDS-PAGE and silver staining confirmed that the protein-depleted solution had no detectable Hsp70 protein or protein fragments. (Fig. 1A shows the result for mycHsp70; similar results were seen for rhuHsp70; not shown.) Testing for calcium signaling we observed that the mycHsp70 protein-depleted solution induced a calcium signal in DCs that was essentially equivalent to that seen with the complete commercial mycHsp70 protein preparation (Fig. 1A). We then used an in-house rhu-Hsp70 preparation, which had undergone a less rigorous dialysis after ATP affinity chromatography, as well a commercially available human Hsp70 (Stressgen (ESP-555). Our less dialyzed rhuHsp70(nc+) preparation induced a calcium flux comparable in magnitude to the commercial mycHsp70 (Fig. 1B), the commercial rhuHsp70 (Stressgen) induced a lower signal. We then depleted the rhuHsp70 protein from the less dialyzed protein solution as performed for mycHsp70 and tested the resultant protein-free solution for its ability to induce a calcium flux in DCs. As was found for the mycHsp70 preparation, the protein-depleted solution of rhuHsp70 triggered identical calcium responses as seen with the protein-containing solution (Fig. 1C, upper panel: red line versus dotted black line). Next, we tested titered solutions of commercial ADP and observed dose-dependent calcium signals (Fig. 1C, lower panel). A 370 nm ADP solution, which corresponded to the calculated amount of residual free nucleotide in our less dialyzed rhu-Hsp70, gave an identical signal (Fig. 1C, lower panel: black line versus red line). At 370 nm ADP, the calcium response of DCs was not in saturation (Fig. 1C, lower panel: 370 nm versus 1 μm ADP), yet the magnitude of the response to 300 nm rhuHsp70 was not higher than that achieved with the protein-free solution (Fig. 1C, upper panel) suggesting that ADP/ATP nucleotides within that Hsp70 preparation were responsible for the calcium influx with no or minimal contribution of the rhuHsp70 protein itself. Consistent with this interpretation, we found that the response induced by this less dialyzed (nucleotide-containing) rhuHsp70 protein preparation was completely blocked by the purinoreceptor antagonist, suramin, as was the response to the ADP solution (Fig. 1C, upper panel). To confirm the conclusion that the mycHsp70 and rhuHsp70 proteins themselves do not cause calcium signals in DCs, we used an extensively dialyzed preparation of rhuHsp70, and the C-terminal substrate binding domain of mycHsp70, mycHsp70-(359–625) previously described as conferring biologic activity with regards to calcium signaling, antigen binding, and T cell activation (19MacAry P.A. Javid B. Floto R.A. Smith K.G. Oehlmann W. Singh M. Lehner P.J. Immunity. 2004; 20: 95-106Abstract Full Text Full Text PDF PubMed Scopus (94) Google Scholar). Importantly, this protein lacks the ATP binding domain and is therefore not purified via ATP-agarose. Neither the rhuHsp70 nor the mycHsp70-(359–625) induced a calcium signal in DCs (Fig. 2A). Because mycHsp70-associated calcium signals have been reported to be mediated through CCR5 binding, we also measured the level of surface CCR5 expression of our DCs by fluorescent-activated cell sorting (FACS) analysis. As shown in Fig. 2B, the DCs used in these experiments were CCR5-positive excluding the possibility that an absence of CCR5 could have caused the failure to induce a calcium signal. Additionally, we analyzed surface marker expression and cytokine secretion of DCs before and after incubation with rhuHsp70. Two rhuHsp70 preparations were compared: one was strongly dialyzed and therefore depleted of nucleotides (no calcium signaling activity), the other was less dialyzed and contained nucleotides (calcium signaling activity). All Hsp70 preparations were carefully endotoxin-depleted and induced no changes in DC phenotype or cytokine secretion (see Ref. 17Bendz H. Ruhland S.C. Pandya M.J. Hainzl O. Riegelsberger S. Brauchle C. Mayer M.P. Buchner J. Issels R.D. Noessner E. J. Biol. Chem. 2007; 282: 31688-31702Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). LPS was used as a control. As shown in Fig. 3A, the rhuHsp70 preparations did not change surface markers CD86, CD80, CD40, or CD83, regardless whether they contained nucleotides and had calcium signaling activity or were highly purified and did not cause calcium signals. LPS up-regulated these markers. Similarly, neither the nucleotide-containing nor the nucleotide-depleted rhuHsp70 preparation in its endotoxin-depleted form modulated the cytokine or chemokine profile of DCs, while LPS induced the secretion these factors (Fig. 3B; IL-10, IL-12p70, and TNF-α are shown as representative examples. IL-6, GM-CSF, CCL5/RANTES were also unchanged; not shown). These results indicate that low concentrations of nucleotides, as present in less dialyzed rhuHsp70 preparations, which cause calcium signals in DCs, do not change phenotypic markers or cytokine secretion, while surface markers and cytokine/chemokine secretion can be induced by LPS consistent with its TLR signaling activity (see references in Ref. 17Bendz H. Ruhland S.C. Pandya M.J. Hainzl O. Riegelsberger S. Brauchle C. Mayer M.P. Buchner J. Issels R.D. Noessner E. J. Biol. Chem. 2007; 282: 31688-31702Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). We did not perform these analyses with mycHsp70, because the available commercial source of mycHsp70 is reported to be contaminated by flagellin (24Ye Z. Gan Y.H. J. Biol. Chem. 2007; 282: 4479-4484Abstract Full Text Full Text PDF PubMed Scopus (62) Google Scholar), which is known to up-regulate phenotypic markers and induce cytokine and chemokine secretion through TLR5 (25Means T.K. Hayashi F. Smith K.D. Aderem A. Luster A.D. J. Immunol. 2003; 170: 5165-5175Crossref PubMed Scopus (335) Google Scholar). Because we lacked the tools to measure or remove flagellin from protein preparations it would have been beyond our scope to distinguish mcyHsp70 effects from those of potential flagellin contamination. Human and Mycobacterial Hsp70 Enhance Cross-presentation without Involving Calcium Signals or CCR5—CCR5 binding and calcium signaling were reported to be closely linked to the T cell stimulatory activity of mycHsp70 (12Floto R.A. MacAry P.A. Boname J.M. Mien T.S. Kampmann B. Hair J.R. Huey O.S. Houben E.N. Pieters J. Day C. Oehlmann W. Singh M. Smith K.G. Lehner P.J. Science. 2006; 314: 454-458Crossref PubMed Scopus (130) Google Scholar, 13Whittall T. Wang Y. Younson J. Kelly C. Bergmeier L. Peters B. Singh M. Lehner T. Eur. J. Immunol. 2006; 36: 2304-2314Crossref PubMed Scopus (54) Google Scholar). Given that the calcium signals of mycHsp70 or huHsp70 were caused by nucleotide contamination of the protein preparations, we then asked whether in the absence of calcium signals, it was possible to observe mycHsp70-mediated antigen cross-presentation and T-cell activation. To address this question we tested the non-signaling preparation of mycHsp70-(325–625) in our cross-presentation system (17Bendz H. Ruhland S.C. Pandya M.J. Hainzl O. Riegelsberger S. Brauchle C. Mayer M.P. Buchner J. Issels R.D. Noessner E. J. Biol. Chem. 2007; 282: 31688-31702Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar) and compared its ability to activate T cells to the dialyzed non-signaling rhuHsp70. The key elements of the system are highly purified Hsp70 proteins, the antigenic peptide pep70-MART-1 and the respective antigen-specific CTL. APCs were incubated in parallel settings with identical concentrations of peptide either with or without the addition of Hsp70. Peptide and Hsp70 are incubated to allow complex formation. The efficacy of peptide cross-presentation was quantified by the ability of APCs to induce an IFN-γ response in antigen-specific CTL as described (17Bendz H. Ruhland S.C. Pandya M.J. Hainzl O. Riegelsberger S. Brauchle C. Mayer M.P. Buchner J. Issels R.D. Noessner E. J. Biol. Chem. 2007; 282: 31688-31702Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar). As APCs we selected the CCR5-negative B cell line LCL721.45 to evaluate in parallel the importance of CCR5 expression. As shown in Fig. 4, a 2-fold higher IFN-γ response was obtained when peptide was delivered to the APCs as a complex with either mycHsp70-(325–625) or rhuHsp70. These results demonstrate that mycHsp70 enhances antigen cross-presentation similar to rhuHsp70, and neither rhuHsp70 nor mycHsp70 requires CCR5 or calcium for this process. Here we demonstrate that highly purified rhuHsp70 protein and the C-terminal mycHsp70 fragment, mycHsp70-(325–625) do not induce calcium signals in APCs nor do they require CCR5 or calcium signals to enhance exogenous antigen cross-presentation for T cell stimulation. Importantly, we found that nucleotides and possibly other, yet to be identified, contaminants within recombinant human and mycobacterial Hsp70 preparations (including those of commercial suppliers) cause calcium signals in myeloid DCs. As reported previously (17Bendz H. Ruhland S.C. Pandya M.J. Hainzl O. Riegelsberger S. Brauchle C. Mayer M.P. Buchner J. Issels R.D. Noessner E. J. Biol. Chem. 2007; 282: 31688-31702Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar), the Hsp70-mediated activity to stimulate antigen-specific T cell responses is strictly dependent on the ability of Hsp70 to form complexes with the exogenous peptide without requiring Hsp70-induced DC phenotypic or secretory changes. The now observed independency of calcium signaling further strengthens the conclusion that the ability of Hsp70s (human and bacterial alike) to activate adaptive immune responses may simply be an extension of their biochemical activity as molecular chaperones and there is no need to assign new activities to Hsp70 proteins to explain this immunological activity. A similar conclusion was reached by others (26Bausinger H. Lipsker D. Hanau D. Trends Immunol. 2002; 23: 342-343Abstract Full Text Full Text PDF PubMed Scopus (27) Google Scholar, 27Tobian A.A. Canaday D.H. Boom W.H. Harding C.V. J. Immunol. 2004; 172: 5277-5286Crossref PubMed Scopus (87) Google Scholar, 28Tobian A.A. Harding C.V. Canaday D.H. J. Immunol. 2005; 174: 5209-5214Crossref PubMed Scopus (48) Google Scholar). Endotoxins were the first identified contaminants of Hsp70 and other HSP preparations (29Bausinger H. Lipsker D. Ziylan U. Manie S. Briand J.P. Cazenave J.P. Muller S. Haeuw J.F. Ravanat C. de la Salle H. Hanau D. Eur. J. Immunol. 2002; 32: 3708-3713Crossref PubMed Scopus (206) Google Scholar, 30Wallin R.P. Lundqvist A. More S.H. von Bonin A. Kiessling R. Ljunggren H.G. Trends Immunol. 2002; 23: 130-135Abstract Full Text Full Text PDF PubMed Scopus (499) Google Scholar, 31Tsan M.F. Gao B. J. Leukoc Biol. 2004; 76: 514-519Crossref PubMed Scopus (603) Google Scholar). Unnoticed as contaminants, their stimulatory effects on DCs had led to the wrong conclusion that HSP proteins themselves have DC stimulatory capacity. Today HSP protein preparations are generally controlled for endotoxin contamination. Nevertheless, these early reports obtained with uncontrolled HSP preparations are still being used to support the postulate that HSPs have innate immune stimulatory capacity (for examples, see references 22, 43, 44 in Ref. 32Pockley A.G. Muthana M. Calderwood S.K. Trends Biochem. Sci. 2008; 33: 71-79Abstract Full Text Full Text PDF PubMed Scopus (203) Google Scholar, reference 5 in Ref. 33Vega V.L. Rodriguez-Silva M. Frey T. Gehrmann M. Diaz J.C. Steinem C. Multhoff G. Arispe N. De Maio A. J. Immunol. 2008; 180: 4299-4307Crossref PubMed Scopus (330) Google Scholar, and reference 61 in Ref. 34Tesniere A. Panaretakis T. Kepp O. Apetoh L. Ghiringhelli F. Zitvogel L. Kroemer G. Cell Death Differ. 2008; 15: 3-12Crossref PubMed Scopus (361) Google Scholar). New contaminants with bioactivity on DCs and other APCs have recently emerged. Nucleotides, as detailed in this report, can now be added to the list. Nucleotides have been shown to cause calcium signals in DCs (17Bendz H. Ruhland S.C. Pandya M.J. Hainzl O. Riegelsberger S. Brauchle C. Mayer M.P. Buchner J. Issels R.D. Noessner E. J. Biol. Chem. 2007; 282: 31688-31702Abstract Full Text Full Text PDF PubMed Scopus (109) Google Scholar, 21la Sala A. Ferrari D. Corinti S. Cavani A. Di Virgilio F. Girolomoni G. J. Immunol. 2001; 166: 1611-1617Crossref PubMed Scopus (188) Google Scholar, 22Marteau F. Communi D. Boeynaems J.M. Suarez Gonzalez N. J. Leukoc Biol. 2004; 76: 796-803Crossref PubMed Scopus (70) Google Scholar, 23Schnurr M. Toy T. Shin A. Wagner M. Cebon J. Maraskovsky E. Blood. 2005; 105: 1582-1589Crossref PubMed Scopus (182) Google Scholar). Thus, previously reported calcium signals observed in experiments using Hsp70 (12Floto R.A. MacAry P.A. Boname J.M. Mien T.S. Kampmann B. Hair J.R. Huey O.S. Houben E.N. Pieters J. Day C. Oehlmann W. Singh M. Smith K.G. Lehner P.J. Science. 2006; 314: 454-458Crossref PubMed Scopus (130) Google Scholar, 13Whittall T. Wang Y. Younson J. Kelly C. Bergmeier L. Peters B. Singh M. Lehner T. Eur. J. Immunol. 2006; 36: 2304-2314Crossref PubMed Scopus (54) Google Scholar, 35Asea A. Kraeft S.K. Kurt-Jones E.A. Stevenson M.A. Chen L.B. Finberg R.W. Koo G.C. Calderwood S.K. Nat. Med. 2000; 6: 435-442Crossref PubMed Scopus (1371) Google Scholar) need to be carefully reconsidered. An additional example is flagellin, which was recently shown to “contaminate” microbial Hsp70, but less so Hsp70 from eukaryotic sources (24Ye Z. Gan Y.H. J. Biol. Chem. 2007; 282: 4479-4484Abstract Full Text Full Text PDF PubMed Scopus (62) Google Scholar). Flagellin is a TLR5 agonist and can efficiently stimulate DCs to up-regulate phenotypic markers, to secrete chemokines and cytokines (25Means T.K. Hayashi F. Smith K.D. Aderem A. Luster A.D. J. Immunol. 2003; 170: 5165-5175Crossref PubMed Scopus (335) Google Scholar). Importantly, microbial Hsp70 proteins are considered to be better immune adjuvants than eukaryotic Hsp70 given that microbial Hsp70 were found to “stimulate” DC maturation and chemokine secretion even after endotoxin depletion (36Javid B. MacAry P.A. Lehner P.J. J. Immunol. 2007; 179: 2035-2040Crossref PubMed Scopus (111) Google Scholar). While this was thought to be related to their pathogen-derived nature, the recent discovery of flagellin in mycHsp70 preparations suggests that this interpretation may need to be reconsidered. As chaperones, HSPs have a high intrinsic binding capacity for hydrophobic protein sequences, nucleotides and endotoxins (37Mayer M.P. Bukau B. Cell Mol. Life Sci. 2005; 62: 670-684Crossref PubMed Scopus (2091) Google Scholar, 38Habich C. Kempe K. van der Zee R. Rumenapf R. Akiyama H. Kolb H. Burkart V. J. Immunol. 2005; 174: 1298-1305Crossref PubMed Scopus (80) Google Scholar, 39Triantafilou M. Triantafilou K. Trends Immunol. 2002; 23: 301-304Abstract Full Text Full Text PDF PubMed Scopus (600) Google Scholar). Thus, HSP protein preparations are prone to “contaminations” with proteins and non-proteinous substances, some of which may be difficult to remove. High standards of purification, stringent analyses of all recombinant HSP protein products for by-products and carefully controlled experimentation are indispensable to allow a precise attribution of biological function to HSP proteins and to pave the way for the utilization of their immunologic activity. We acknowledge the excellent technical assistance of K. Nispel, A. Brandl, and D. Neumann, and thank Prof. Dr. Mahavir Singh of Lionex Diagnostics & Therapeutics GmbH for discussion." @default.
• W2080352912 created "2016-06-24" @default.
• W2080352912 creator A5014518109 @default.
• W2080352912 creator A5055114869 @default.
• W2080352912 creator A5057531099 @default.
• W2080352912 creator A5072612103 @default.
• W2080352912 creator A5079225181 @default.
• W2080352912 creator A5080949843 @default.
• W2080352912 creator A5086069152 @default.
• W2080352912 date "2008-09-01" @default.
• W2080352912 modified "2023-09-26" @default.
• W2080352912 title "Calcium Signaling in Dendritic Cells by Human or Mycobacterial Hsp70 Is Caused by Contamination and Is Not Required for Hsp70-mediated Enhancement of Cross-presentation" @default.
• W2080352912 cites W1491815146 @default.
• W2080352912 cites W1515599953 @default.
• W2080352912 cites W1555041989 @default.
• W2080352912 cites W1580317357 @default.
• W2080352912 cites W1602279356 @default.
• W2080352912 cites W1671931635 @default.
• W2080352912 cites W1787932591 @default.
• W2080352912 cites W1866826175 @default.
• W2080352912 cites W1877412971 @default.
• W2080352912 cites W1936786886 @default.
• W2080352912 cites W1971756409 @default.
• W2080352912 cites W1973266914 @default.
• W2080352912 cites W1973661844 @default.
• W2080352912 cites W1982062578 @default.
• W2080352912 cites W1986974750 @default.
• W2080352912 cites W2001015172 @default.
• W2080352912 cites W2028041423 @default.
• W2080352912 cites W2029123674 @default.
• W2080352912 cites W2050812895 @default.
• W2080352912 cites W2058676815 @default.
• W2080352912 cites W2069163264 @default.
• W2080352912 cites W2071044011 @default.
• W2080352912 cites W2075923636 @default.
• W2080352912 cites W2083064282 @default.
• W2080352912 cites W2088087142 @default.
• W2080352912 cites W2090084038 @default.
• W2080352912 cites W2090799771 @default.
• W2080352912 cites W2101285879 @default.
• W2080352912 cites W2104251106 @default.
• W2080352912 cites W2109936231 @default.
• W2080352912 cites W2113769407 @default.
• W2080352912 cites W2126019239 @default.
• W2080352912 cites W2131424980 @default.
• W2080352912 cites W2134347949 @default.
• W2080352912 cites W2139731109 @default.
• W2080352912 cites W2145196632 @default.
• W2080352912 cites W2147709293 @default.
• W2080352912 cites W2163443542 @default.
• W2080352912 cites W3140953116 @default.
• W2080352912 doi "https://doi.org/10.1074/jbc.m803310200" @default.
• W2080352912 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3258906" @default.
• W2080352912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18658155" @default.
• W2080352912 hasPublicationYear "2008" @default.
• W2080352912 type Work @default.
• W2080352912 sameAs 2080352912 @default.
• W2080352912 citedByCount "35" @default.
• W2080352912 countsByYear W20803529122012 @default.
• W2080352912 countsByYear W20803529122013 @default.
• W2080352912 countsByYear W20803529122014 @default.
• W2080352912 countsByYear W20803529122016 @default.
• W2080352912 countsByYear W20803529122017 @default.
• W2080352912 countsByYear W20803529122018 @default.
• W2080352912 countsByYear W20803529122019 @default.
• W2080352912 countsByYear W20803529122020 @default.
• W2080352912 countsByYear W20803529122022 @default.
• W2080352912 crossrefType "journal-article" @default.
• W2080352912 hasAuthorship W2080352912A5014518109 @default.
• W2080352912 hasAuthorship W2080352912A5055114869 @default.
• W2080352912 hasAuthorship W2080352912A5057531099 @default.
• W2080352912 hasAuthorship W2080352912A5072612103 @default.
• W2080352912 hasAuthorship W2080352912A5079225181 @default.
• W2080352912 hasAuthorship W2080352912A5080949843 @default.
• W2080352912 hasAuthorship W2080352912A5086069152 @default.
• W2080352912 hasBestOaLocation W20803529121 @default.
• W2080352912 hasConcept C104317684 @default.
• W2080352912 hasConcept C112570922 @default.
• W2080352912 hasConcept C126838900 @default.
• W2080352912 hasConcept C178790620 @default.
• W2080352912 hasConcept C185592680 @default.
• W2080352912 hasConcept C18903297 @default.
• W2080352912 hasConcept C201571599 @default.
• W2080352912 hasConcept C203014093 @default.
• W2080352912 hasConcept C205260736 @default.
• W2080352912 hasConcept C2776090121 @default.
• W2080352912 hasConcept C2777601897 @default.
• W2080352912 hasConcept C2778973524 @default.
• W2080352912 hasConcept C519063684 @default.
• W2080352912 hasConcept C55493867 @default.
• W2080352912 hasConcept C68991219 @default.
• W2080352912 hasConcept C71924100 @default.
• W2080352912 hasConcept C83464605 @default.
• W2080352912 hasConcept C86803240 @default.
• W2080352912 hasConcept C8891405 @default.
• W2080352912 hasConcept C89423630 @default.
• W2080352912 hasConcept C95444343 @default.
• W2080352912 hasConceptScore W2080352912C104317684 @default.

• next